Tradestie Institutional Equity Comparison Engine
UL vs CLX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CLX Overall Edge
CLX Captures Institutional Edge (3โ1 Pillars ยท 4โ6 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Clorox Company (CLX) driven by superior Valuation, Momentum & Technical, Options & Structure while UL counters with relative strength in Growth & Margin. Fundamentally, UL trades at 18.5x Forward P/E with 20.0% operating margin (+0.5% YoY revenue) versus CLX at 17.6x Forward P/E and 14.3% operating margin (+33.3% YoY). In options structure, UL sits in UNCLASSIFIED (13th %ile IV; Dealer Gamma Walls on Pro) against CLX sits in SURGE (25th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
CLX
UL 18.5x vs CLX 17.6x Fwd P/E
Growth & Margin Winner
UL
Op Margin 20.0% vs 14.3% ยท YoY +0.5% vs +33.3%
Momentum & Technical Winner
CLX
1Y +8.4% vs +6.4% ยท 52W Pos 45% vs 51%
Options & Structure Winner
CLX
UNCLASSIFIED (13th %ile IV) vs SURGE (25th %ile IV)
UL
NYSE
Unilever plc
Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics
$63.82
+0.73% 1D
Market Cap
$136.4B
1M Return
-4.75%
1Y Return
+8.41%
Forward P/E
18.5x
Unified AI Score
46.7 / 100
HOLD
Tech 47.0
Fund 45.0
Flow 50.0
Mom 36.0
CLX
NYSE
Clorox Company
Specialty Cleaning, Polishing And Sanitation Preparations
$104.73
-0.16% 1D
Market Cap
$12.7B
1M Return
+18.13%
1Y Return
+6.4%
Forward P/E
17.6x
Unified AI Score
29.7 / 100
SELL
Tech 50.0
Fund 32.0
Flow 57.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
UL +8.41%
CLX +6.4%
Spread: +2.01 pp (UL Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
UL TTM Op. Margin: 20.0%
CLX TTM Op. Margin: 14.3%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on UL vs CLX. Trailing 12-month operating profitability (UL 20.0% vs CLX 14.3%) and valuation multiples (UL 18.5x vs CLX 17.6x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | UL | CLX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $136.4B | $12.7B | Larger Scale | UL |
| Trailing P/E Ratio Valuation | 13.0x | 18.9x | Lower Multiple | UL |
| Forward P/E Ratio Valuation | 18.5x | 17.6x | Lower Multiple | CLX |
| Revenue Growth (YoY) Growth | +0.5% | +33.3% | Higher Growth | CLX |
| Operating Margin (TTM) Profitability | 20.0% | 14.3% | Higher Margin | UL |
| Net Profit Margin Profitability | 18.3% | 9.4% | Higher Margin | UL |
| Return on Equity (ROE) Capital Efficiency | 31.9% | 53.4% | Higher ROE | CLX |
| 52-Week Range Position Momentum | 45% ($55โ$75) | 51% ($79โ$129) | Stronger Trend | CLX |
| Beta / 30D Volatility Risk Regime | -0.03ฮฒ ยท 24% Vol | 0.43ฮฒ ยท 37% Vol | Lower Realized Risk | UL |
| Unified Institutional Score Composite Signal | 46.7 / 100 (HOLD) | 29.7 / 100 (SELL) | Higher Composite | UL |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full UL vs CLX Buy Guide
UL
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
13th %ile
IV Regime
Compressed (<25th %ile)
CLX
SURGE
5d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
25th %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither UL nor CLX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.